Search research articles
Contact Us
Filters
Showing results (21-30 of 77) with videos related to
Page
of 8
Sort By:
Biomedicines
|
August 26, 2022
Soluble (Pro)Renin Receptor Levels Are Regulated by Plasma Renin Activity and Correlated with Edema in Mice and Humans with HFrEF
Inna P Gladysheva, Ryan D Sullivan, Kodangudi Ramanathan, et al.
The Journal of Biological Chemistry
|
April 21, 2012
Streptococcus uberis plasminogen activator (SUPA) activates human plasminogen through novel species-specific and fibrin-targeted mechanisms
Yi Zhang, Inna P Gladysheva, Aiilyan K Houng, et al.
The Journal of Biological Chemistry
|
June 25, 2002
Structural elements that govern the substrate specificity of the clot-dissolving enzyme plasmin
Ryan B Turner, Lin Liu, Irina Y Sazonova, et al.
Neuroscience
|
January 19, 2021
Matrix Metalloproteinase-9 Expression is Enhanced by Ischemia and Tissue Plasminogen Activator and Induces Hemorrhage, Disability and Mortality in Experimental Stroke
Sofiyan Saleem, Dong Wang, Tieqiang Zhao, et al.
International Journal of Molecular Sciences
|
September 14, 2024
Differences in Acute Expression of Matrix Metalloproteinases-9, 3, and 2 Related to the Duration of Brain Ischemia and Tissue Plasminogen Activator Treatment in Experimental Stroke
Dong Wang, Sofiyan Saleem, Ryan D Sullivan, et al.
Circulation. Heart Failure
|
January 11, 2011
Decompensated heart failure is associated with reduced corin levels and decreased cleavage of pro-atrial natriuretic peptide
Uzoma N Ibebuogu, Inna P Gladysheva, Aiilyan K Houng, et al.
JACC. Basic to Translational Science
|
May 28, 2025
Recent Pathophysiological Insights Are Advancing the Treatment of Venous Thromboembolism
Satish Singh, Pardeep Kumar, Sudesh K Yadav, et al.
Circulation
|
September 9, 2024
Targeting Fibrinolytic Inhibition for Venous Thromboembolism Treatment: Overview of an Emerging Therapeutic Approach
Satish Singh, Pardeep Kumar, Yogendra S Padwad, et al.
International Journal of Cardiology
|
February 8, 2008
Can dysfunctional HDL explain high coronary artery disease risk in South Asians?
Sunita Dodani, Rajwinderjit Kaur, Srinavasa Reddy, et al.
Biochemistry
|
July 10, 2007
Regulation of nonproteolytic active site formation in plasminogen
Inna P Gladysheva, Irina Y Sazonova, Aiilyan Houng, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 77) with videos related to
Sort By:
Page
of 8
Biomedicines
|
August 26, 2022
Soluble (Pro)Renin Receptor Levels Are Regulated by Plasma Renin Activity and Correlated with Edema in Mice and Humans with HFrEF
Inna P Gladysheva, Ryan D Sullivan, Kodangudi Ramanathan, et al.
The Journal of Biological Chemistry
|
April 21, 2012
Streptococcus uberis plasminogen activator (SUPA) activates human plasminogen through novel species-specific and fibrin-targeted mechanisms
Yi Zhang, Inna P Gladysheva, Aiilyan K Houng, et al.
The Journal of Biological Chemistry
|
June 25, 2002
Structural elements that govern the substrate specificity of the clot-dissolving enzyme plasmin
Ryan B Turner, Lin Liu, Irina Y Sazonova, et al.
Neuroscience
|
January 19, 2021
Matrix Metalloproteinase-9 Expression is Enhanced by Ischemia and Tissue Plasminogen Activator and Induces Hemorrhage, Disability and Mortality in Experimental Stroke
Sofiyan Saleem, Dong Wang, Tieqiang Zhao, et al.
International Journal of Molecular Sciences
|
September 14, 2024
Differences in Acute Expression of Matrix Metalloproteinases-9, 3, and 2 Related to the Duration of Brain Ischemia and Tissue Plasminogen Activator Treatment in Experimental Stroke
Dong Wang, Sofiyan Saleem, Ryan D Sullivan, et al.
Circulation. Heart Failure
|
January 11, 2011
Decompensated heart failure is associated with reduced corin levels and decreased cleavage of pro-atrial natriuretic peptide
Uzoma N Ibebuogu, Inna P Gladysheva, Aiilyan K Houng, et al.
JACC. Basic to Translational Science
|
May 28, 2025
Recent Pathophysiological Insights Are Advancing the Treatment of Venous Thromboembolism
Satish Singh, Pardeep Kumar, Sudesh K Yadav, et al.
Circulation
|
September 9, 2024
Targeting Fibrinolytic Inhibition for Venous Thromboembolism Treatment: Overview of an Emerging Therapeutic Approach
Satish Singh, Pardeep Kumar, Yogendra S Padwad, et al.
International Journal of Cardiology
|
February 8, 2008
Can dysfunctional HDL explain high coronary artery disease risk in South Asians?
Sunita Dodani, Rajwinderjit Kaur, Srinavasa Reddy, et al.
Biochemistry
|
July 10, 2007
Regulation of nonproteolytic active site formation in plasminogen
Inna P Gladysheva, Irina Y Sazonova, Aiilyan Houng, et al.
Page
of 8